{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:40:17Z","timestamp":1790390417365,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,12,3]],"date-time":"2008-12-03T00:00:00Z","timestamp":1228262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00259-008-1000-1","type":"journal-article","created":{"date-parts":[[2008,12,2]],"date-time":"2008-12-02T13:13:44Z","timestamp":1228223624000},"page":"671-682","source":"Crossref","is-referenced-by-count":36,"title":["Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography"],"prefix":"10.1007","volume":"36","author":[{"given":"Anne","family":"Roivainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"N\u00e5gren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Hirvonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa","family":"Oikonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauliina","family":"Virsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula","family":"Tolvanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha O.","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,3]]},"reference":[{"key":"1000_CR1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","volume":"27","author":"V Papadopoulos","year":"2006","unstructured":"Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacap\u00e8re JJ, Lindemann P, et al. Translocator protein (18\u00a0kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 2006;27:402\u2013409.","journal-title":"Trends Pharmacol Sci"},{"key":"1000_CR2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0197-0186(01)00118-8","volume":"40","author":"P Casellas","year":"2002","unstructured":"Casellas P, Galiegue S, Basile AS. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 2002;40:475\u2013486.","journal-title":"Neurochem Int"},{"key":"1000_CR3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0304-4157(95)00016-X","volume":"241","author":"KE Krueger","year":"1995","unstructured":"Krueger KE. Molecular and functional properties of mitochondrial benzodiazepine receptors. Biochim Biophys Acta 1995;241:453\u2013470.","journal-title":"Biochim Biophys Acta"},{"key":"1000_CR4","doi-asserted-by":"crossref","first-page":"E102","DOI":"10.1093\/nar\/29.21.e102","volume":"29","author":"L Skrabanek","year":"2001","unstructured":"Skrabanek L, Campagne F. TissueInfo: high-throughput identification of tissue expression profiles and specificity. Nucleic Acids Res 2001;29:E102.","journal-title":"Nucleic Acids Res"},{"key":"1000_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2164-4-31","volume":"4","author":"L Huminiecki","year":"2003","unstructured":"Huminiecki L, Lloyd AT, Wolfe KH. Congruence of tissue expression profiles from Gene Expression Atlas, SAGEmap and TissueInfo databases. BMC Genomics 2003;4:31.","journal-title":"BMC Genomics"},{"key":"1000_CR6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ana.410260611","volume":"26","author":"L Junck","year":"1989","unstructured":"Junck L, Olson JM, Ciliax BJ, Koeppe RA, Watkins GL, Jewett DM, et al. PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann Neurol 1989;26:752\u2013758.","journal-title":"Ann Neurol"},{"key":"1000_CR7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5","volume":"50","author":"E Vowinckel","year":"1997","unstructured":"Vowinckel E, Reutens D, Becher B, Verge G, Evans A, Owens T, et al. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res 1997;50:345\u2013353.","journal-title":"J Neurosci Res"},{"key":"1000_CR8","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/brain\/123.11.2321","volume":"123","author":"RB Banati","year":"2000","unstructured":"Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 2000;123:2321\u20132337.","journal-title":"Brain"},{"key":"1000_CR9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","volume":"15","author":"MR Turner","year":"2004","unstructured":"Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 2004;15:601\u2013609.","journal-title":"Neurobiol Dis"},{"key":"1000_CR10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","volume":"57","author":"Y Ouchi","year":"2005","unstructured":"Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, et al. Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease. Ann Neurol 2005;57:168\u2013175.","journal-title":"Ann Neurol"},{"key":"1000_CR11","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1212\/WNL.55.7.1052","volume":"55","author":"S Pappata","year":"2000","unstructured":"Pappata S, Levasseur M, Gunn RN, Myers R, Crouzel C, Syrota A, et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology 2000;55:1052\u20131054.","journal-title":"Neurology"},{"key":"1000_CR12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.jcbfm.9600092","volume":"25","author":"MA Kropholler","year":"2005","unstructured":"Kropholler MA, Boellaard R, Schuitemaker A, van Berckel BN, Luurtsema G, Windhorst AD, et al. Development of a tracer kinetic plasma input model for (R)-[11C]PK11195 brain studies. J Cereb Blood Flow Metab 2005;25:842\u2013851.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1000_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0378-4347(99)00439-9","volume":"736","author":"F Vos De","year":"1999","unstructured":"De Vos F, Dumont F, Santens P, Slegers G, Dierckx R, De Reuck J. High-performance liquid chromatographic determination of [11C]-1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide in mouse plasma and tissue and in human plasma. J Chromatogr B Biomed Sci Appl 1999;736:61\u201366.","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"1000_CR14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.73.3.476","volume":"73","author":"P Charbonneau","year":"1986","unstructured":"Charbonneau P, Syrota A, Crouzel C, Valois J-M, Prenant C, Crouzel M. Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography. Circulation 1986;73:476\u2013483.","journal-title":"Circulation"},{"key":"1000_CR15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0969-8051(93)90082-6","volume":"20","author":"VW Pike","year":"1993","unstructured":"Pike VW, Halldin C, Crouzel C, Barr\u00e9 L, Nutt DJ, Osman S, et al. Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites \u2013 current status. Nucl Med Biol 1993;20:503\u2013525.","journal-title":"Nucl Med Biol"},{"key":"1000_CR16","first-page":"518","volume":"32","author":"SK Luthra","year":"1993","unstructured":"Luthra SK, Osman S, Turton DR, Vaja V, Dowsett K, Brady F. An automated system based on solid phase extraction and HPLC for the routine determination in plasma of unchanged [11C]-L-deprenyl; [11C]diprenorphine; [11C]flumazenil; [11C]raclopride; and [11C]Scherring 23390. J Labelled Compd Radiopharm 1993;32:518\u2013520.","journal-title":"J Labelled Compd Radiopharm"},{"key":"1000_CR17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1468-1331.2003.00571.x","volume":"10","author":"JC Debruyne","year":"2003","unstructured":"Debruyne JC, Versijpt J, Van Laere KJ, De Vos F, Keppens J, Strijckmans K, et al. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195. Eur J Neurol 2003;10:257\u2013264.","journal-title":"Eur J Neurol"},{"key":"1000_CR18","first-page":"1398","volume":"35","author":"TR DeGrado","year":"1994","unstructured":"DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994;35:1398\u20131406.","journal-title":"J Nucl Med"},{"key":"1000_CR19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.jcbfm.9600339","volume":"27","author":"AJ Montgomery","year":"2007","unstructured":"Montgomery AJ, Asselin MC, Farde L, Grasby PM. Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET. J Cereb Blood Flow Metab 2007;27:369\u2013377.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1000_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nucmedbio.2004.12.005","volume":"32","author":"HNJM Greuter","year":"2005","unstructured":"Greuter HNJM, van Ophemert PLB, Luurtsema G, van Berckel BN, Franssen EJ, Windhorst BD, et al. Optimizing an online SPE\u2013HPLC method for analysis of (R)-[11C]1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide [(R)-[11C]PK11195] and its metabolites in humans. Nucl Med Biol 2005;32:307\u2013312.","journal-title":"Nucl Med Biol"},{"key":"1000_CR21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/phrs.1999.0617","volume":"41","author":"EP Wala","year":"2000","unstructured":"Wala EP, Sloan JW, Jing X. Pharmacokinetics of the peripheral benzodiazepine receptor antagonist, PK 11195, in rats. The effect of dose and gender. Pharmacol Res 2000;41:461\u2013468.","journal-title":"Pharmacol Res"},{"key":"1000_CR22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1472-8206.1989.tb00679.x","volume":"3","author":"A Ferry","year":"1989","unstructured":"Ferry A, Jaillon P, Lecocq B, Lecocq V, Jozefczak C. Pharmacokinetics and effects on exercise heart rate of PK 11195 (52028 RP), an antagonist of peripheral benzodiazepine receptors, in healthy volunteers. Fundam Clin Pharmacol 1989;3:383\u2013392.","journal-title":"Fundam Clin Pharmacol"},{"key":"1000_CR23","first-page":"S88","volume":"46","author":"MC Cleij","year":"2003","unstructured":"Cleij MC, Airbirhio FJ, Baron JC, Clark JC. Base-promoted dechlorination of (R)-[11C]PK 11195. J Labelled Compd Radiopharm 2003;46:S88.","journal-title":"J Labelled Compd Radiopharm"},{"key":"1000_CR24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0197-4580(91)90106-T","volume":"12","author":"D Diorio","year":"1991","unstructured":"Diorio D, Weiner SA, Butterworth RF, Meaney Mi, Suranyi-Cadotte BE. Peripheral benzodiazepine binding sites in Alzheimer\u2019s disease frontal and temporal cortex. Neurobiol Aging 1991;12:255\u2013258.","journal-title":"Neurobiol Aging"},{"key":"1000_CR25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","volume":"358","author":"A Cagnin","year":"2001","unstructured":"Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, et al. In-vivo measurement of activated microglia in dementia. Lancet 2001;358:461\u2013467.","journal-title":"Lancet"},{"key":"1000_CR26","first-page":"P752","volume":"32","author":"P Virsu","year":"2005","unstructured":"Virsu P, Laitinen I, P\u00f6yh\u00f6nen T, N\u00e5gren K, Roivainen A. In vivo biodistribution, biokinetics and blood metabolism of 11C-PK11195 in rats \u2013 a PET tracer for peripheral benzodiazepine receptor. Eur J Nucl Med Mol Imaging 2005;32:P752.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-008-1000-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-008-1000-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-008-1000-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:01:43Z","timestamp":1558699303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-008-1000-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,3]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["1000"],"URL":"https:\/\/doi.org\/10.1007\/s00259-008-1000-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,3]]}}}